United Services Automobile Association Vertex Pharmaceuticals Inc Transaction History

United Services Automobile Association

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$225.48 - $295.8 $4.47 Million - $5.87 Million	-19,843 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$199.77 - $247.81 $149,228 - $185,114	-747 Reduced 3.63%	19,843 $4.45 Million
Q4 2019 Jan 14, 2020	SELL	$166.71 - $223.91 $1.7 Million - $2.28 Million	-10,177 Reduced 33.08%	20,590 $4.51 Million
Q3 2019 Nov 13, 2019	SELL	$166.23 - $187.09 $46.5 Million - $52.3 Million	-279,469 Reduced 90.08%	30,767 $5.21 Million
Q2 2019 Aug 16, 2019	BUY	$164.61 - $190.37 $4.96 Million - $5.73 Million	30,111 Added 10.75%	310,236 $56.9 Million
Q1 2019 May 13, 2019	BUY	$163.73 - $194.7 $2.69 Million - $3.2 Million	16,440 Added 6.23%	280,125 $51.5 Million
Q4 2018 Feb 13, 2019	BUY	$151.91 - $192.21 $162,999 - $206,241	1,073 Added 0.41%	263,685 $43.7 Million
Q3 2018 Nov 13, 2018	BUY	$167.73 - $192.74 $412,951 - $474,525	2,462 Added 0.95%	262,612 $50.6 Million
Q2 2018 Sep 27, 2018	SELL	$145.72 - $169.96 $901 Million - $1.05 Billion	-6,183,761 Reduced 95.96%	260,150 $44.2 Million
Q2 2018 Aug 10, 2018	BUY	$145.72 - $169.96 $904 Million - $1.05 Billion	6,204,725 Added 2594.1%	6,443,911 $234 Million
Q1 2018 May 14, 2018	BUY	$151.6 - $177.13 $6.86 Million - $8.01 Million	45,236 Added 23.32%	239,186 $39 Million
Q4 2017 Feb 14, 2018	BUY	$137.28 - $155.55 $3.97 Million - $4.5 Million	28,906 Added 17.51%	193,950 $29.1 Million
Q3 2017 Nov 14, 2017	BUY	$148.13 - $162.24 $24.4 Million - $26.8 Million	165,044	165,044 $25.1 Million

1,723

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

Stay updated on United Services Automobile Association with notifications on news.